PRGO Share Price

Open 67.05 Change Price %
High 68.32 1 Day 0.76 1.13
Low 65.79 1 Week 1.38 2.08
Close 67.81 1 Month -0.15 -0.22
Volume 3234007 1 Year -31.74 -31.88
52 Week High 111.00
52 Week Low 65.47
PRGO Important Levels
Resistance 2 70.16
Resistance 1 69.19
Pivot 67.31
Support 1 66.43
Support 2 65.46
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
AKRX 33.09 1.13%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
WRES 0.09 28.57%
More..
NASDAQ USA Top Gainers Stocks
PGRX 0.06 100.00%
SPIR 0.02 100.00%
LOCM 0.09 50.00%
RITT 0.03 50.00%
CLNT 4.50 30.81%
CALI 3.45 29.21%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

Perrigo Company (NASDAQ: PRGO)

PRGO Technical Analysis 5
As on 25th Apr 2017 PRGO Share Price closed @ 67.81 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 85.18 & Strong Sell for SHORT-TERM with Stoploss of 72.60 we also expect STOCK to react on Following IMPORTANT LEVELS.
PRGO Target for April
1st Target up-side 71.95
2nd Target up-side 75.85
3rd Target up-side 79.74
1st Target down-side 60.83
2nd Target down-side 56.93
3rd Target down-side 53.04
PRGO Other Details
Segment EQ
Market Capital 10823602176.00
Sector Healthcare
Industry Drug Related Products
Offical website http://www.perrigo.com
PRGO Address
PRGO
Treasury Building
Lower Grand Canal Street
Dublin, 2
Ireland
Phone: 353 1 604 0031
PRGO Latest News
Interactive Technical Analysis Chart Perrigo Company ( PRGO NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Perrigo Company
PRGO Business Profile
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. Its businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia. In February 2013, it completed the acquisition of Leeds, United Kingdom-based Rosemont Pharmaceuticals Ltd. In April 2013, it closed the acquisition of Velcera, Inc. In June 2013, the Company acquired an ophthalmic sterile ointment and solution product portfolio from Fera Pharmaceuticals, LLC. In December 2013, it acquired Elan Corporation Plc.